BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAPA-GP - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://sapagp.org
X-WR-CALDESC:Events for SAPA-GP
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231008T110000
DTEND;TZID=America/New_York:20231008T150000
DTSTAMP:20260425T074604
CREATED:20230919T000606Z
LAST-MODIFIED:20230919T000606Z
UID:4625-1696762800-1696777200@sapagp.org
SUMMARY:SAPA-GP 2023 Fall Picnic
DESCRIPTION:register now
URL:https://sapagp.org/event/sapa-gp-2023-fall-picnic/
LOCATION:Upper Providence Blackrock Park\, 1286 Black Rock Road\, Phoenixville\, PA\, 19460\, United States
CATEGORIES:Event,In Person
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2023/09/https___cdn.evbuc_.com_images_594364999_202745421483_1_original.jpeg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230920T210000
DTEND;TZID=America/New_York:20230920T220000
DTSTAMP:20260425T074604
CREATED:20230907T144313Z
LAST-MODIFIED:20231003T154735Z
UID:4617-1695243600-1695247200@sapagp.org
SUMMARY:BioVerse: Where Science Sparks Business Sept 2023
DESCRIPTION:This event has ended. Please scroll down for the recording.Catherine PearceDHSc\, MBADr. Pearce started her career in 1997 at Hoffman-LaRoche\, then at Merck launching therapeutics in the cardiovascular space. In 2001\, Dr. Pearce joined a small CRO\, Medpace\, as a Clinical Project Manager. She led hundreds of global Phase 1-4 studies in a variety of therapeutic areas\, including neurology\, diabetes\, lipid-lowering\, kidney diseases\, and obesity. She started the first business development team and marketing teams at Medpace in 2011. In 2013\, Dr. Pearce joined Teva as VP\, R&D\, leading a new division dedicated to evaluating generics for repurposing. One of the most recognizable efforts to come from this program was the approval of Uzedy in 2023 for the treatment of schizophrenia. Uzedy was approved in partnership with Medincell\, which was a collaboration her team had spearheaded. In 2015\, Dr. Pearce decided to come back to her hometown of Cincinnati\, OH to co-found a biotech incubator\, CinRx. The idea of launching a biotech portfolio company seemed timely Dr. Pearce: the thesis was to take early-stage or “shelved” assets from pharma\, biotech\, or academia and develop them through proof-of-concept to be acquired by large pharma with commercial capabilities. During her time at CinRx\, Dr. Pearce developed 6 “Cin” portfolio companies in areas such as oncology\, obesity\, gastroparesis\, and hypertension. When CinCor’s Board decided the strategic exit of this company’s novel aldosterone synthase inhibitor was a public offering\, Dr. Pearce spun out with the organization to build the company’s infrastructure and help take it public. After the asset\, baxdrostat\, demonstrated its value in the Phase 2 BrigHtn study published in the New England Journal of Medicine\, the company was eventually acquired by AstraZeneca in February 2023 in a transaction worth up to $1.8B.\nToday\, Dr. Pearce is once again embarking on the idea that forming a company around early-stage or shelved assets is a necessary endeavor. This time\, though\, she is using her experience to build stronger clinical development teams\, Advisory Boards\, strategic partners\, and financial backers to evaluate novel therapeutics and design the ideal trials to demonstrate the benefits and safety of life-saving medicines for the patients that need them. As the CEO of newly formed JucaBio\, she is excited about the future of drug development and the possibilities of bringing additional therapeutics to patients worldwide in areas of high unmet medical needs.\nIn addition to sitting on a number of private biotech Boards\, Dr. Pearce is an advisor to several start-ups and a Board of Trustee Member at Xavier University\, where she received her undergraduate education and MBA. She received her Doctorate in Health Sciences from Nova Southeastern University. Dr. Pearce is married with 3 children and is a fitness enthusiast\, book lover\, traveler\, and avid cook. Dr. Pearce lives by three creeds: say “yes” many more times than you say “no\,” never ask someone to do work you are unwilling or unable to do yourself\, and — importantly — always look for a little fun along the way.
URL:https://sapagp.org/event/bioverse-where-science-sparks-business/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/09/featured-image-9-20-2023-webinar.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230727T200000
DTEND;TZID=America/New_York:20230727T213000
DTSTAMP:20260425T074604
CREATED:20230714T154859Z
LAST-MODIFIED:20230714T154859Z
UID:4564-1690488000-1690493400@sapagp.org
SUMMARY:Beyond FDA Approval: Assessing Pharmaceutical Market Access Risk for Drug Development Strategy
DESCRIPTION:REGISTER HERE
URL:https://sapagp.org/event/beyond-fda-approval-assessing-pharmaceutical-market-access-risk-for-drug-development-strategy/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/07/0727-webinar-feature.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230623
DTEND;VALUE=DATE:20230625
DTSTAMP:20260425T074604
CREATED:20230607T230200Z
LAST-MODIFIED:20230607T230200Z
UID:4537-1687478400-1687651199@sapagp.org
SUMMARY:2nd Annual SAPA-GP @Philly Cell Gene Therapy Conference
DESCRIPTION:REGISTER HERE
URL:https://sapagp.org/event/2nd-annual-sapa-gp-philly-cell-gene-therapy-conference/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AtPhilly,Event,In Person
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2023/06/cgt_featuered.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230609T210000
DTEND;TZID=America/New_York:20230609T223000
DTSTAMP:20260425T074604
CREATED:20230607T004735Z
LAST-MODIFIED:20230607T004735Z
UID:4531-1686344400-1686349800@sapagp.org
SUMMARY:ASCO2023 Recap: The Winners\, Losers\, and Black Horses
DESCRIPTION:REGISTER HERE
URL:https://sapagp.org/event/asco2023-recap-the-winners-losers-and-black-horses/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/06/ASCO_featured_recap.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230530T210000
DTEND;TZID=America/New_York:20230530T223000
DTSTAMP:20260425T074604
CREATED:20230526T142648Z
LAST-MODIFIED:20230526T142648Z
UID:4495-1685480400-1685485800@sapagp.org
SUMMARY:Preview of ASCO by BioSpark/ISWTC/SAPA-GP
DESCRIPTION:REGISTER HERESpeakersModeratorOrganizers
URL:https://sapagp.org/event/preview-of-asco-by-biospark-iswtc-sapa-gp/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/05/featuered-image.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230517T180000
DTEND;TZID=America/New_York:20230517T203000
DTSTAMP:20260425T074604
CREATED:20230514T002908Z
LAST-MODIFIED:20230514T005959Z
UID:4465-1684346400-1684355400@sapagp.org
SUMMARY:@Philly Company Showcase & Networking Dinner
DESCRIPTION:
URL:https://sapagp.org/event/philly-company-showcase-networking-dinner/
LOCATION:Jin Ding Restaurant\, 1051 Conestoga Rd\, Bryn Mawr\, PA\, 19010\, United States
CATEGORIES:AtPhilly,Career Events,Event,In Person
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2023/05/pdf_20230510_095448_0000.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230331T120000
DTEND;TZID=America/New_York:20230401T190000
DTSTAMP:20260425T074604
CREATED:20230118T023035Z
LAST-MODIFIED:20230329T122928Z
UID:4163-1680264000-1680375600@sapagp.org
SUMMARY:SAPA-GP 2023 Annual Conference
DESCRIPTION:SAPA-GP 2023 Annual Conference: Embracing New Technologies in a Changing World \nRegister NowAgendaMarch 31st – April 1st\, 2023 (In-Person)\nSheraton Valley Forge Hotel\n480 N Gulph Rd\, King of Prussia\, PA 19406\nClick here to register or scan the QR code on the right.\nDuring the past few years\, the pharmaceutical industry has experienced dramatic changes due to COVID 19 pandemic and technological advancements.  Many of those changes are transforming the industry and speeding up the pace of new drug development. On the technological front\, new drug targets have been discovered at ever increasing speed. AI assisted drug discovery is opening new frontiers. Digital technologies\, decentralized clinical studies\, and real-world evidence are reshaping clinical development. On the business front\, creative business models are weathering the current market downturn and rejuvenating fresh investment\, mergers and acquisitions (M&A)\, and partnership around the world. Regarding patient access\, in responding to skyrocketing price tags of new drugs\, adaptive payment mechanisms have been devised in hope of delivering lifesaving medicines to patients in a sustainable way. \nOn Mar 31st – Apr. 1st\, 2023\, SAPA-GP will hold 2023 annual conference at King of Prussia\, PA. There will be 5 Parallel Tracks: \n\nScientific: Pioneering a New Era of Drug Discovery & Development: Novel Targets\, Innovative Platforms\, and Recent Regulations\nClinical: New Trends in Clinical Development\nBusiness: The Business Engine of New Drug Development: Fundraising\, BD\, and Commercialization\nMarket Research: Promoting Patient Access after Regulatory Approval\nCareer: Career Development\, Diversity\, Labor Law\, and Roundtable Discussion\n\nWe are excited to have Dr. Amir Kalali and Dr. Virginia Man-Yee Lee\, two well-known experts as our keynote speakers\, to share insights from both scientific and clinical perspectives. Moreover\, Dr. Tim Opler will discuss M&A transactions across the pharmaceutical industry\, and Dr. Joga Gobburu will talk about model-informed drug development. \nCheck out our list of top-notch speakers and sponsors: \nRegister NowStay tuned for more speakers and agenda. \nBecoming our Annual Conference sponsors with these benefits:\n• Exhibition booths at the Annual Conference\n• Company showcases in the conference brochure and website\n• Guest speaker slots in parallel sessions\n• A platform for reaching out to potential business partners\n• Far-reaching market penetration via email blasts\, LinkedIn\, and WeChat groups\n• Great opportunities for talent recruitment… and more! For sponsorship opportunities\, please contact: bd@sapa-gp.org \nDo you want to become a Volunteer for SAPA-GP Annual Conference and future events? please contact: sapagp@sapa-gp.org \nRefer to our website for the Refund and Transfer policy and Student Discount. \nSAPA-GP\, supported by the collective wisdom of professionals in the pharmaceutical industry\, strives to shine insight into how the pharmaceutical industry is adapting to the evolving environment and transforming itself into the new era of biopharma 2.0. The SAPA-GP 2023 Annual Conference will be a unique opportunity for people to come together to celebrate the transformation underway\, and more importantly\, to brainstorm how to ride the tide to success. \nCheck out more events on SAPA-GP website or scan the QR code below.
URL:https://sapagp.org/event/sapa-gp-2023-annual-conference/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AC,Event,In Person
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2023/01/banner.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230126T200000
DTEND;TZID=America/New_York:20230126T213000
DTSTAMP:20260425T074604
CREATED:20230119T131125Z
LAST-MODIFIED:20230120T033331Z
UID:4225-1674763200-1674768600@sapagp.org
SUMMARY:Humanized mouse models to accelerate drug development - SAPA-GP Webinar Jan 26\, 2023
DESCRIPTION:Register HereSanti s. ChenAssociate Director\, Immunology and Oncology\, GemPharmatechSanti is a research scientist and business development professional with over 10 years of experience in autoimmune disease\, immunology\, and oncology disease areas. Santi received her training in human B cell development at the Garvan Institute of Medical Research Australia in Immunology\, followed by a postdoctoral fellowship at the Children’s Cancer Institute Australia\, focusing on pediatric leukemia and therapies. Her projects include testing agents’ efficacy and mechanisms such as navitoclax\, venetoclax\, and selumetinib. Her research projects resulted in multiple publications in journals such as Blood and Journal of Immunology and national/international awards.Sponsored by GemPharmatechGemPharmatech\, a leading provider of mouse models and preclinical services\, offers a one-stop solution for in vivo studies with a collection of more than 20\,000 strains including KO/cKO\, humanized\, disease\, germ-free and custom models\, as well as custom breeding services. \nSponsored by GemPharmatech; Contact: sales@gempharmatech.us
URL:https://sapagp.org/event/4225/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/01/Featured-pic.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221209T090000
DTEND;TZID=America/New_York:20221209T153000
DTSTAMP:20260425T074604
CREATED:20221201T171457Z
LAST-MODIFIED:20221201T173243Z
UID:4104-1670576400-1670599800@sapagp.org
SUMMARY:SAPA-GP Career Development Workshop
DESCRIPTION:Ignite Your Career GrowthWhat are your career goals for 2023? \n\nGet promoted?\nChange to a different role?\nBe more effective in your current role?\nMove from a technical to business role?\n\nIf so\, this Career Development Workshop is for YOU! \nCome learn and build your network \nREGISTER HERE!FEATURED SPEAKERSDavid CraginSenior Director\, Product ScienceTeva PharmaceuticalsCheryl PaesVP\, Head of MarketingCenter for Breakthrough MedicinesJing YangCo-founder & Board DirectorBaseCure TherapeuticsJamie HuangFounderPrinceton Leadership AcademyJoe LingleChief People OfficerCenter for Breakthrough MedicinesPan PanDirector of Business DevelopmentAkeso\, Inc.Audrey GreenbergCo-Founder & Chief Business OfficerCenter for Breakthrough MedicinesAgenda8:30am – 9:00am \n9:00am – 9:30am \nRegistration \nOpening remark & Keys to On-line and In-person networking \nDavid Cragin \nSenior Director\, Product Science \nTeva Pharmaceuticals \n9:30am – 10:00am \nTopic 1: The secrets of HR \nJoe Lingle \nChief People Officer \nCenter for Breakthrough Medicines \n10:00am – 10:30am \n1030am – 11:00am \nNetworking Break I \nTopic 2: Take a Chance on Unexpected Opportunities \nJing Yang \nCo-founder & Board Director \nBaseCure Therapeutics \n11:00am – 11:30am \nPanel Discussion \nAudrey Greenberg \nCo-Founder and Chief Business Officer \nCenter for Breakthrough Medicines \nJing Yang \nCo-founder & Board Director \nBaseCure Therapeutics \n11:30am – 1:00pm \n1:00pm – 1:40pm \nLunch Break \nTopic 3: Getting off the Sticky Floor \nJamie Huang \nFounder \nPrinceton Leadership Academy \n1:40pm – 2:00pm \n2:00pm – 2:40pm \nNetworking Break II \nTopic 4: A Path from R&D to Business Development \nPan Pan \nDirector of Business Dvelopment \nAkeso\, Inc \n2:40pm – 3:10pm \nPanel Discussion \nCheryl Paes \nVP\, Head of Marketing \nCenter for Breakthrough Medicines \nPan Pan \nDirector of Business Development \nAkeso\, Inc. \nScan QR code for registration\, or follow this registration link: \nhttps://www.eventbrite.com/e/sapa-gp-2022-career-development-workshop-igniting-your-career-growth-tickets-467770322627
URL:https://sapagp.org/event/sapa-gp-career-development-workshop/
LOCATION:The Center for Breakthrough Medicines\, 411 Swedeland Road\, #100\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:Career Events,Event,In Person,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2022/12/featured.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221110T200000
DTEND;TZID=America/New_York:20221110T213000
DTSTAMP:20260425T074604
CREATED:20221104T222406Z
LAST-MODIFIED:20221105T122416Z
UID:4080-1668110400-1668115800@sapagp.org
SUMMARY:Mouse Models for Disease Mechanism Studies and Drug R&D
DESCRIPTION:Register HereXiang Gao\, Ph.D.Founder and Chairman of GemPharmatechXiang Gao is an alumina of Nanjing University. He received his Ph.D. degree from Thomas Jefferson University in 1994\, then did his postdoctoral training at the Jackson Lab. In 2000\, Xiang was recruited back as professor at Nanjing University. Where he founded both Model Animal Research Center of NJU and National Resource Center of Mutant Mice of China. He was the associate dean of Medical School and director for the State Key Laboratory of Pharmaceutical Biotechnology. Xiang is the recipient for Cheung Kong Scholar from Ministry of Education and Distinguished Young Scholar from National Science Foundation. His lab has been focused on understanding the physiological homeostasis of metabolic and immunological processes. He has been funded by multiple national grants and published more than 200 research papers. Xiang is recipient of many national and international awards\, including the National Science and Technology Progress Award. In 2017\, Xiang founded GemPharmatech (GPT) which has become the leading company for animal model generation and application. GPT is the largest mutant mouse resource center in the world and now holds more than 22\,000 mutant mouse strains. GPT went IPO early this year at STAR market in Shanghai Exchange.Sponsored by: GemPharmatech\nGemPharmatech\, a leading provider of mouse models and preclinical services. With a collection of 20\,000+ strains\, GPT offers KO/cKO\, humanized\, disease\, and custom models\, as well as a one-stop solution for in vivo studies. Contact: brook.white@gempharmatech.us
URL:https://sapagp.org/event/mouse-models-for-disease-mechanism-studies-and-drug-rd/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2022/11/Nov.-10-Webinar-feature.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220915T200000
DTEND;TZID=America/New_York:20220915T213000
DTSTAMP:20260425T074604
CREATED:20220910T144808Z
LAST-MODIFIED:20220911T223208Z
UID:3944-1663272000-1663277400@sapagp.org
SUMMARY:Accelerating Cell & Gene Therapy Innovations: NK Cell Therapy\, Preclinical Solutions\, and CRO
DESCRIPTION:Register HereDongfang LiuAssociate Professor/Director of Immunoassay Development ProgramDongfang Liu\, Ph.D.\, an Associate Professor and Director of Immunoassay Development Program at the Department of Pathology\, Immunology and Laboratory Medicine in Rutgers University- New Jersey Medical School. In 2012\, Dr. Liu was recruited to Baylor College of Medicine as a tenure-track Assistant Professor in the Department of Pediatrics\, and Pathology & Immunology\, before joining Houston Methodist Research Institute (HMRI) as an Assistant Professor in 2015. In 2018\, Dr. Liu was promoted to an Associate Professor in HMRI. Dr. Liu did his Ph.D. and postdoctoral training on natural killer (NK) cells. After completing the postdoctoral training\, he joined Ragon Institute of MGH\, MIT and Harvard in 2011 as a senior research scientist\, where he worked on HIV-specific immune cell dysfunction. Dr. Liu’s research is primarily focused on the immunobiology of NK and chimeric antigen receptor (CAR)-NK cells. He has more than 20 years’ experience in NK cell research. Dr. Liu has published research papers in top-tier journals\, including Nature Immunology\, Immunity\, Nature Communications\, JACI\, Proc. Natl. Acad. Sci.\, and others. Dr. Liu serves on several editorial boards for multiple journals and as a reviewer for a number of journals and several grant agencies.Santi ChenAssociate Director\, Immunology and Oncology\, GemPharmatechSanti is a research scientist and business development professional with over 10 years of experience in autoimmune disease\, immunology\, and oncology disease areas. Santi received her training in human B cell development at the Garvan Institute of Medical Research Australia in Immunology\, followed by a postdoctoral fellowship at the Children’s Cancer Institute Australia\, focusing on pediatric leukemia and therapies. Her projects include testing agents’ efficacy and mechanisms such as navitoclax\, venetoclax\, and selumetinib. Her research projects resulted in multiple publications in journals such as Blood and Journal of Immunology and national/international awards. \nSponsored by GemPharmatechGemPharmatech\, a leading provider of mouse models and preclinical services. With a collection of 21\,000 strains\, GPT offers KO/cKO\, humanized\, disease\, and custom models\, as well as a one-stop solution for in vivo studies. \nContact: keila.woods@gempharmatech.us
URL:https://sapagp.org/event/accelerating-cell-gene-therapy-innovations-nk-cell-therapy-preclinical-solutions-and-cro/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2022/09/Flyer-Sept-15_feature.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220617
DTEND;VALUE=DATE:20220619
DTSTAMP:20260425T074604
CREATED:20220428T020820Z
LAST-MODIFIED:20220911T023723Z
UID:3688-1655424000-1655596799@sapagp.org
SUMMARY:@Philly Cell & Gene Therapy Annual Conference 2022
DESCRIPTION:
URL:https://sapagp.org/event/philly-cell-gene-therapy-annual-conference-2022/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AtPhilly,Event,In Person
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2022/04/Screen-Shot-2022-04-16-at-08.29.05.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220524T200000
DTEND;TZID=America/New_York:20220524T213000
DTSTAMP:20260425T074604
CREATED:20220511T191641Z
LAST-MODIFIED:20220911T022309Z
UID:3816-1653422400-1653427800@sapagp.org
SUMMARY:Finding your Pathway to Success - Career meeting
DESCRIPTION:Register Here
URL:https://sapagp.org/event/finding-your-pathway-to-success-career-meeting/
CATEGORIES:Career Events,Event,Webex Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220415T120000
DTEND;TZID=America/New_York:20220416T190000
DTSTAMP:20260425T074604
CREATED:20220314T012254Z
LAST-MODIFIED:20220911T023850Z
UID:3622-1650024000-1650135600@sapagp.org
SUMMARY:Turbo Charging Innovation in the New Decade of Life Sciences --- US-China Biopharma Congress - SAPA-GP 2022 Annual Conference (Hybrid)
DESCRIPTION:Turbo Charging Innovation in the New Decade of Life Sciences  Sheraton Valley Forge Hotel\n480 N Gulph Rd\, King of Prussia\, PA 19406\nor\nthrough Online Platform and Mobile App \nRegister Here中国地区平台注册AgendaProgram Brochure As the flagship event of SAPA-GP\, our Annual Conference attracted over 1\,000 attendees each year\, featuring presentations and panel discussions by distinguished speakers and panelists from academia\, industry\, and regulatory authorities\, to provide opportunities for scientific exchange\, public health education\, networking\, career development\, and business collaborations. After two years of postponement due to the pandemic situation\, we have decided that it is time to host the annual conference again\, through a hybrid platform\, which allows for both local participants to enjoy the social networking again\, and global participants to connect from all over the world without geographic restrictions. You can join us from Anywhere!\n\n1 week final count down! Register now or onsite. \n3 Parallel Tracks:\n\nScientific track: Redefining pharmaceutical innovation from bench to bedside\nBusiness track: Unleashing the power from scientific breakthroughs and entrepreneurship (Co-branding with BioKatalyst)\nCareer track: Preparing life scientists for the future\n\n\nAgenda and Speakers Highlights below:\n\nFor detailed Agenda\, please check here or click on the Agenda Tab.\n\nEnjoy the benefits of Hybrid Platform: \nOnline: \n\n\nAccess to mobile app for program navigation and live stream of all presentations.\nSchedule 1-1 meetings with all attendees including sponsors through mobile app and online platform.\nRandom matchmaking and speed networking\n1 month access to cloud recording of presentation videos\n\nOnsite:\n\nAll benefits from online\nFood & beverage included (worth $80/person)\nFriday: Snack Bar (4-5pm)\, free coffee\nSaturday: Lunch box (11:30 am-12:30pm) & Snack Bar (4-5pm)\, free coffee\nAttend company show cases and opportunities of direct contact/mock interview with hiring manager from 10+ prestigious pharmaceutical companies.\nSocial networking with speakers and other attendees from pharmaceutical industry\nAttend career development workshops and join 1-1 SAPA-GP mentoring program\n\nSponsors
URL:https://sapagp.org/event/turbo-charging-innovation-in-the-new-decade-of-life-sciences-us-china-biopharma-congress-sapa-gp-2022-annual-conference-hybrid/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AC,Event
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2022/03/AC2022.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220216T200000
DTEND;TZID=America/New_York:20220216T213000
DTSTAMP:20260425T074604
CREATED:20220203T214246Z
LAST-MODIFIED:20220911T024014Z
UID:3605-1645041600-1645047000@sapagp.org
SUMMARY:Create a High Impact First Impression!
DESCRIPTION:Register Here
URL:https://sapagp.org/event/create-a-high-impact-first-impression/
CATEGORIES:Career Events,Webex Meeting
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220120T200000
DTEND;TZID=America/New_York:20220120T213000
DTSTAMP:20260425T074604
CREATED:20220114T180932Z
LAST-MODIFIED:20220911T024025Z
UID:3593-1642708800-1642714200@sapagp.org
SUMMARY:Insights on cross-border private financing and IPO environment & alternatives
DESCRIPTION:Register HereSpeakers Bios:Rebecca ChanPartner\, Deloitte HKRebecca Chan is a senior audit partner with over 33 years of experience working with international accounting firms as well as the Stock Exchange of Hong Kong Limited. Before joining Deloitte\, Rebecca had acted as the Senior Vice President of the Hong Kong Exchanges and Clearing Limited\, where she headed the IPO Transactions Department and the Accounting Affairs Department of the Listing Division. She has been heavily involved in providing accounting and listing rules advice and working on initial public offerings and post-listing transactions. Apart from auditing and capital market experience\, Rebecca has been involved in advisory and due diligence work such as a feasibility study on building up an exchange\, reviewing internal control systems\, assisting in formulation of financial reporting and accounting policies\, providing tax services for listed and unlisted companies and participating in projects that aimed at comparing and making suggestions for regulatory rules of various overseas Stock Exchanges or markets\, including markets in ASEAN countries\, Taiwan\, the Middle East and Europe.\nRebecca is a Member of HKICPA and a Fellow Member of The Institute of Chartered Accountants in England and Wales.Yiming LiuPartner\, CooleyYiming Liu is a partner of Cooley’s global capital markets team. He represents companies and investment funds on strategic transactions in the life sciences and technology industries. Yiming regularly advises clients on the structuring\, negotiation and documentation of a wide range of cross-border transactions\, including mergers and acquisitions\, private equity financings\, joint ventures\, research collaborations and licensing arrangements. In addition\, Yiming is widely recognized for his work on life sciences IPOs in Hong Kong and the US. With advanced degrees in molecular\, cellular and developmental biology and health services administration\, Yiming leverages his technical background to help clients achieve desired results. He received his JD from Columbia University\, MS in Molecular\, Cellular and Developmental Biology and MHSA (Health Services Administration) from University of Michigan\, and BS (Biological Sciences) from Fudan University.Patrick LoofbourrowPartner\, CooleyPatrick Loofbourrow is a co-founder of Cooley’s Shanghai office and splits his time across Cooley’s Asia and California offices. Patrick’s practice focuses on the representation of high-growth emerging technology and life sciences companies as well as venture capital and other firms that invest in those companies across Asia and the US. Concentrating on corporate and securities law\, he has counseled company clients and investors in a wide variety of projects\, including company formations\, spin-offs\, private and public financings\, initial public offerings\, mergers and acquisitions\, joint venture and other strategic transactions\, employee equity incentives\, corporate governance matters and SEC reporting and compliance. Patrick counsels companies in a variety of industries\, including biotechnology\, digital health\, healthcare\, medical devices\, fintech\, ecommerce\, edtec and software.\nPatrick received his JD\, summa cum laude from the University of San Diego School of Law in 1999\, where he was elected to the Order of the Coif and served as Lead Editor of the San Diego Law Review. He completed joint Bachelor’s degrees in International Relations and Anthropology\, with an emphasis in Latin America\, at Stanford University in 1988. Patrick is bilingual in Spanish and English and has lived in Ecuador.Lili ZhengPartner\, Deloitte USLili Zheng is responsible for Deloitte’s overall cross-functional services to Chinese clients investing in the US. She currently serves as the Deloitte’s Asia Pacific Cross Border Services Leader and Deputy Managing Partner of Deloitte US Chinese Services Group. Lili is a senior US international tax partner with substantial experience in cross-border tax planning. Leveraging on her extensive experience in Deloitte offices in San Francisco\, Tokyo\, Beijing\, San Jose and Hong Kong\, she provides practical and implementable solutions to companies on their cross-border investments\, JV planning\, M&A\, entry and exit strategies. She has extensive knowledge advising clients ranging from start-up to sizable multinational companies and in various industries including life sciences & healthcare\, consumer products\, e-commerce\, TMT\, VC/PE funds\, and manufacturing. Fluent in Chinese\, she has a deep understanding of the unique considerations of investors with Asian backgrounds.\nOutside Deloitte\, Lili is a member of the Board of Directors at Huayuan Science and Technology Association in Silicon Valley\, and a member of BayHelix. Lili received her B.S.\, Accounting and Finance from UC Berkeley and M.S. in Taxation from Golden Gate University. She is a licensed CPA in California and New York and a member of AICPA.Sponsor: The Deloitte Chinese Services Group (CSG) provides professional support for life sciences and healthcare companies engaged in cross-border investments and business between Greater China region and the United States. https://bit.ly/2IX5MDf
URL:https://sapagp.org/event/insights-on-cross-border-private-financing-and-ipo-environment-alternatives/
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211111T200000
DTEND;TZID=America/New_York:20211111T210000
DTSTAMP:20260425T074604
CREATED:20211018T174916Z
LAST-MODIFIED:20221201T192250Z
UID:3560-1636660800-1636664400@sapagp.org
SUMMARY:Instinct in Decision Making: Good or Bad for you?
DESCRIPTION:Register Here
URL:https://sapagp.org/event/instinct-in-decision-making-good-or-bad-for-you/
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/10/11-11-flyer-e1634579319778.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T200000
DTEND;TZID=America/New_York:20211006T210000
DTSTAMP:20260425T074604
CREATED:20210926T125738Z
LAST-MODIFIED:20221201T192320Z
UID:3553-1633550400-1633554000@sapagp.org
SUMMARY:Health Economics Outcomes Research and its Future in Life Sciences
DESCRIPTION:Register HereSponsor:This event is sponsored by Sino Biological\, a global leader in recombinant technology; In-house developed mammalian cell-based recombinant expression system; Completive price and fast turnaround for Recombinant Production service; Largest viral antigen bank\, ProVir collection.
URL:https://sapagp.org/event/health-economics-outcomes-research-and-its-future-in-life-sciences/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/09/Oct.6-Webinar-e1632661007537.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210715T200000
DTEND;TZID=America/New_York:20210715T213000
DTSTAMP:20260425T074604
CREATED:20210702T001923Z
LAST-MODIFIED:20221201T192628Z
UID:3502-1626379200-1626384600@sapagp.org
SUMMARY:Cell & Gene Therapy (CGT) Rapid Growth in China: What Could be Your Share of the Pie?
DESCRIPTION:Register HereSpeakers:Amit AgarwalManaging Director\, Life Sciences San Francisco\, CA Amit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations Amit co-leads the Next Generation Therapies practice. The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space. Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects.\nAmit also has experience as Vice President at Leerink Swann & Co.\, a boutique investment bank focused on the life sciences. He helped innovative life science companies raise capital\, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker.\nAmit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine. Amit has presented at multiple conferences in North America\, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms.\nAmit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and premed from Occidental College. Prior to business school\, Amit conducted research in neurobiology at the California Institute ofTechnology and was an American diplomat posted in China and the Middle East. Annie XuSpecialist Leader\, Life Sciences and Health Care\, Deloitte Consulting\, USAI am a core member of Deloitte’s NextGen Practice\, with a focus on helping cell and gene companies set up their supply chain and commercial platform to launch their products globally. I co-lead Deloitte’s Industry Working Group (IWG)\, working closely with industry leaders to design patient-centric solutions that provide CGT access to a broader patient population.\nRelevant experiences:\n1. Developed a digital strategy to support the first gene-editing product launch in the US and EMEA\n2. Performed the market landscape assessment for cell and gene therapies and developed the investment strategy for a PE firm\n3. Led patient journey development and market sizing for an ultra-rare disease gene therapy\, and develop launch strategy in Saudi\, Russia\, Japan\, and Brazil\nSupported commercial site certification across 80+ hospitals within the US for a CAR-T product\n4. Drove the global launch readiness for the most expensive gene therapy product outside of the US\, with a projected $1B sales revenue in 2020David Xie\, PhDPartner\, NextGen expertI’m a Partner based in Shanghai\, China with a focus on biotech and next generation therapies practice. We often take a China specific view and help clients to understand the intricate and fast-evolving policies environment and what it means for entry strategy\, regulatory path\, market access\, and go-to-market models. We also tackle next-generation specific issues such as site certification and supply chain visibility. My experience in CGT:\n1. Led multiple projects with leading overseas biopharma companies to help define China product regulatory paths\, market access and GTMs including CAR-T\, targeted oncology drugs\, and rare disease drugs\n2. Worked on global supply chain and China commercial excellence to define China entry and supply chain models for Cell & Gene Therapies\n3. Worked on the launch of multiple CAR-T products access and pricing strategy in China\n4. Worked on the companion genetic diagnosis tests clinical development and GTM assessment as part of the CGT product portfolio\n5. Represent the Deloitte Next Generation Therapies practice in China with thought leadership on driving In China For China business modelsJohn Law Strategy and Business Design Manager\, Deloitte Consulting\, ChinaJohn is a Shanghai based Manager at the Strategy & Business Design service\nline\, also known as Monitor Deloitte and now part of Strategy\, Analytics and M&A offering portfolio\, of Deloitte Consulting. He studied Biomedical Sciences at University of Oxford where he specialized in scientific data analysis as well as experimental testing; through which he developed a research oriented and data driven approach to solving problems.\nJohn possesses a diverse skill set from strategy to operations in Life Sciences\nand Health Care consulting. His strong written and verbal communication skills also contributed to his successful track record in interacting with clients across levels. John is fluent in English\, Mandarin Chinese and Cantonese Chinese.\nSelected project experience:\n• Assessed China competitive landscape as well as pricing and reimbursement environment for a leading British multinational pharmaco’s hepatocellular carcinoma CAR T; designed likely market access journey for client’s CAR T by formulating various reimbursement scenarios and price volume relationship\n• Evaluated China go to market model options for a leading Japanese multinational pharmco’s portfolio of gene therapies having identified relevant regulatory barriers; designed entry roadmap from entity set up\, clinical trials\, product and materials import to commercialization\n• Estimated China market size and attractiveness for a leading Japanese multinational medical device company’s cell processing center; identified use cases and customer segments and developed unique value propositions\nJohn holds a Master and a Bachelor degree in Biomedical Sciences from University of Oxford.
URL:https://sapagp.org/event/cell-gene-therapy-cgt-rapid-growth-in-china-what-could-be-your-share-of-the-pie/
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/07/July-15-Webinar-e1625185124573.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210616T200000
DTEND;TZID=America/New_York:20210616T210000
DTSTAMP:20260425T074604
CREATED:20210523T001848Z
LAST-MODIFIED:20221201T192640Z
UID:3469-1623873600-1623877200@sapagp.org
SUMMARY:Project Management and Beyond -- What you need to know
DESCRIPTION:Register Here
URL:https://sapagp.org/event/project-management-and-beyond-what-you-need-to-know/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/05/Screen-Shot-2021-05-22-at-17.29.34-PM-e1621729108251.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210531T200000
DTEND;TZID=America/New_York:20210531T200000
DTSTAMP:20260425T074604
CREATED:20210518T131519Z
LAST-MODIFIED:20221201T192650Z
UID:3464-1622491200-1622491200@sapagp.org
SUMMARY:Improve Your Presentations with Stress and Intonation
DESCRIPTION:Register Here
URL:https://sapagp.org/event/improve-your-presentations-with-stress-and-intonation/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/05/20210531-SAPAGP-Flyer-e1621343697926.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210428T200000
DTEND;TZID=America/New_York:20210428T210000
DTSTAMP:20260425T074604
CREATED:20210410T113545Z
LAST-MODIFIED:20221201T192700Z
UID:3446-1619640000-1619643600@sapagp.org
SUMMARY:Demystifying Life Sciences Business Development in the COVID Era
DESCRIPTION:Register Here  \nTopics including\, but not limited to: \n\nprocess around BD inside your organization\nyour role specifically\nBD best practices\nPost-COVID BD\nCareer advice for scientists interested in BD\n\n  \nSpeaker Info: \n\nJean-Sebastien (JS) Cleiftie\, CBO of Erytech Pharma (former Assoc. VP of Sanofi) (Linkedin)\nYelena Wetherill\, Director\, Alliance Management\, Business Development & Licensing at Novartis Institutes for BioMedical Research (NIBR) (Linkedin)\nDan Zheng\, Director for Global Transactions at Sanofi Partnering (Linkedin)\nAmy Jia Wang\, Director\, External R&D (Search & Evaluation) at Horizon (Linkedin)\nSally (Yuanheng) Wang Liang JD MPH\, VP of Business Development @ PepLib (Linkedin)\n\n(Sally will be the moderator and speaker) \n 
URL:https://sapagp.org/event/demystifying-life-sciences-business-development-in-the-covid-era/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/04/Screen-Shot-2021-04-09-at-23.54.31-PM-1-e1618054497276.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210331T200000
DTEND;TZID=America/New_York:20210331T210000
DTSTAMP:20260425T074604
CREATED:20210311T191209Z
LAST-MODIFIED:20221201T192711Z
UID:3428-1617220800-1617224400@sapagp.org
SUMMARY:High Impact Communication Skills
DESCRIPTION:How do you make your talks memorable?\nCan technical talks be made readily understandable?\nWhat are techniques for giving presentations with strong impact?\n\nIf you want answers to these questions and have a chance to network with colleagues\, attend SAPA GP’s career webinar.  We will use Zoom meetings to allow for more opportunities for networking.\n\nSpeakers:\nDavid Cragin\, PhD\, DABT\, Director Global Product Quality Complaint Operations\, Merck & Co\n\nSara Gao\,\n– Program director\, Wharton Executive education\n– Instructor of global village for future leaders of business and industry program\, Lehigh University\n\n\nBrought to you by\nSinoAmerican Pharmaceutical Association Greater Philadelphia\nCareer and Mentoring Group\nRegister HereView Recordings\nSorry\, your browser doesn't support embedded videos.
URL:https://sapagp.org/event/high-impact-communication-skills/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/03/Screen-Shot-2021-03-15-at-21.17.03-PM.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201210T200000
DTEND;TZID=America/New_York:20201210T210000
DTSTAMP:20260425T074604
CREATED:20201202T032256Z
LAST-MODIFIED:20221201T192734Z
UID:3384-1607630400-1607634000@sapagp.org
SUMMARY:Paving the Path to Commercialize Cell & Gene Therapies: Why a New Operating Model is Greatly Needed?
DESCRIPTION:Agenda \n\nRecent CGT market dynamics overview and the outlook\nBest practices for managing the special CGT supply chain and product delivery\nNew reimbursement models on a global basis\n\n\nSpeaker：Amit Agarwal\, Managing Director\, Deloitte Consulting \n\n\nAmit Agarwal \nManaging Director \nLife Sciences \nSan Francisco\, CA  \nAmit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations  Amit co-leads the Next Generation Therapies practice.  The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space.  Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects. \nAmit also has experience as Vice President at Leerink Swann & Co.\, a boutique investment bank focused on the life sciences.  He helped innovative life science companies raise capital\, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker. \nAmit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine.  Amit has presented at multiple conferences in North America\, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms. \nAmit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and pre-med from Occidental College. Prior to business school\, Amit conducted research in neurobiology at the California Institute of Technology and was an American diplomat posted in China and the Middle East. \nThis webinar is sponsored by Deloitte. The Deloitte Chinese Services Group (CSG) provides professional support for life sciences and healthcare companies engaged in cross-border investments and business between Greater China region and the United States. https://bit.ly/2IX5MDf \nRegister Here
URL:https://sapagp.org/event/paving-the-path-to-commercialize-cell-gene-therapies-why-a-new-operating-model-is-greatly-needed/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/12/IMG_6108.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201111T200000
DTEND;TZID=America/New_York:20201111T210000
DTSTAMP:20260425T074604
CREATED:20201013T001500Z
LAST-MODIFIED:20221201T192751Z
UID:3305-1605124800-1605128400@sapagp.org
SUMMARY:Negotiation\, Influence\, and Conflict Resolution in the Office
DESCRIPTION:Speaker:\n1. Dianne Hart\, SHRM-SCP\, DDI\, Global Vice President/Chief Human Resources Officer\, IPS-Integrated Services \n2. David Cragin\, PhD\, DABT\, Director Global Complaint Management and External Affairs\, Merck & Co. \n3. Yangzhou Li\, PharmD\, Medical Writer\, Legend Biotech USA\, Inc. \nRegister Here
URL:https://sapagp.org/event/negotiation-influence-and-conflict-resolution-in-the-office/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/10/Nov-11-flyer-SAPA-GP.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T200000
DTEND;TZID=America/New_York:20201105T213000
DTSTAMP:20260425T074604
CREATED:20201013T000926Z
LAST-MODIFIED:20221201T192809Z
UID:3300-1604606400-1604611800@sapagp.org
SUMMARY:Latest perspectives and trends in global clinical development
DESCRIPTION:Topics and Speakers:\nIncluding China into Your Drug Development Strategy: Why\, When and How?\nJiansong Yang\, PhD\, CSO\, Tigermed\n\nDr. Jiansong Yang is the Chief Scientific Officer of Tigermed\, which is the largest clinical CRO in China. He’s also the Founder and CEO of Mosim (acquired by Tigermed company)\, which focuses on drug development strategy\, clinical study design\, and PK/PD data analysis. \nDr. Yang has over 15 years of experience in the pharmaceutical industry\, specializing in early drug development and clinical study design. Prior to Mosim\, he was Director of Clinical Pharmacology at GSK. He received his Ph.D. in Clinical Pharmacokinetics from the University of Sheffield\, UK. \nThe Future of Global Drug Development Beyond the Pandemic\nAmir Kalali\, MD\, Chairman\, CNS Summit\nDr. Amir Kalali is a physician scientist\, recognized globally as a leading innovator at the intersection of life sciences and technology\, and a convener of collaborative high impact forums. He is the Chairman and Chief Curator of the CNS Summit\, a forum focused on the future of life sciences\, and was the Founding Chairman\, and sits on the Executive Committee of the International Society for CNS Drug Development (ISCDD)\, one of the first independent non-profits to bring together leaders in drug development to collaborate. He has been involved in initiatives by the Institute of Medicine\, as well as the NIH FAST and the NIH NCATS program. Previously\, he was the Global Head of the Neuroscience Center of Excellence at Quintiles\, now known as IQVIA. In this role\, he was responsible for numerous successful drug development programs. He is a Professor of Psychiatry at the University of California San Diego\, Editor of the journal Innovations in Clinical Neuroscience\, and the Lead Editor of the book Essential CNS Drug Development. Dr. Kalali sits on the board of directors of both private and publicly traded companies and advises companies in the life sciences and technology sectors\, universities\, and the investment groups. \nRegister HereSponsored by Tigermed \nWebsite: tigermedgrp.com \nContact: fang.zhao@tigermedgrp.com
URL:https://sapagp.org/event/latest-perspectives-and-trends-in-global-clinical-development/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/10/Nov-5-flyer-SAPA-GP.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T200000
DTEND;TZID=America/New_York:20201014T213000
DTSTAMP:20260425T074604
CREATED:20201009T005503Z
LAST-MODIFIED:20221201T192940Z
UID:3296-1602705600-1602711000@sapagp.org
SUMMARY:Health Economics Outcome Research:  Value Evidence Generation for Life Sciences
DESCRIPTION:Speakers：\n– Lixia Yao\, PhD\, Director Real-world Data Analytics and Innovation\, Merck & Co.\n– Chang Xu\, MS\, Manager Janssen Scientific Affairs\n– Jingyi Qi\, MPH\, Associate Decision Support Analyst\, Gateway Health\n– Yulan Zhang\, MS\, Associate\, HEOR KMK Consulting Inc.\n– Candice Zhi\, Tsinghua University School of Economics and Management\n\nHighlights:\nHealth Economic Outcome Research (HEOR)\, Real Word Evidence and Market Access are rapidly growing fields worldwide\n– Learn about how these techniques are being used to give patients access to medicines\n– Understand the US and China’s approaches to these fields\nRegister Here
URL:https://sapagp.org/event/health-economics-outcome-research-value-evidence-generation-for-life-sciences/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/10/unnamed-1.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T200000
DTEND;TZID=America/New_York:20200924T210000
DTSTAMP:20260425T074604
CREATED:20200917T001443Z
LAST-MODIFIED:20221201T193000Z
UID:2820-1600977600-1600981200@sapagp.org
SUMMARY:The Chinese American Experience: Evolving Tensions in US-China Relations
DESCRIPTION:Title: The Chinese American Experience: Evolving Tensions in US-China Relations \nTime: Thursday\, September 24\, 8:00-9:00 PM\, EDT \nSpeaker: \n\nBrian A. Sun Of Counsel\, Jones Day; Investigations & White Collar Defense\, Business & Tort Litigation\nChristopher K. Pelham Of Counsel\, Jones Day; Global Disputes\, Investigations & White Collar Defense\, Technology\n\nHighlights : \n\n US  government national security concerns\n IP/trade secrets theft\n Organizing and responding to the “loyalty” challenges raised by the current environment and the return of the Fifties type scrutiny and persecution of Asian Pacific Americans\n\nRegister Here Speaker’s BioBrian Sun has earned a national reputation as a distinguished trial lawyer in complex business litigation and white collar criminal defense. He is a former federal prosecutor\, a Fellow of the American College of Trial Lawyers\, and has been named by Lawdragon Magazine as one of America’s 500 leading lawyers. Brian is recognized as a Band 1 lawyer by Chambers in the area of white collar criminal defense and government investigations. He was also Partner-in-Charge of the Los Angeles Office for several years. Brian’s litigation practice covers a wide range of areas\, including matters involving intellectual property disputes\, Foreign Corrupt Practices Act (FCPA)\, public corruption\, entertainment\, contractual disputes\, and fraud. Brian has a substantial cross-border practice\, and his clients include Global Fortune 300 institutions and individuals embroiled in high-stakes litigation. Over the years he has represented such clients as Hon Hai Precision Co. (Foxconn)\, Mattel\, Emerson Electric Co.\, the City of Los Angeles\, and a number of individuals\, including former Orange County Sheriff Michael Carona and Dr. Wen Ho Lee in his successful civil lawsuit against the United States government. Brian is a former president of the National Asian Pacific American Bar Association (NAPABA) and the Los Angeles Regional Foodbank. He has been honored by NAPABA with its Trailblazer Award and by the Southern California Chinese Lawyers Association with its Lifetime Achievement Award. He also served as a deputy general counsel to the Christopher Commission\, which recommended sweeping reforms of the Los Angeles Police Department in the wake of the Rodney King incident. \nChris Pelham is a former Assistant United States Attorney who serves international clients with dispute\, regulatory\, litigation\, and internal investigation needs in China and East Asia. Chris is one of only a small number of American former prosecutors who are based in mainland China. From his location in Shanghai\, Chris provides Chinese and East Asian clients with immediate insight into\, and advice about\, the U.S. litigation and criminal systems. He also provides U.S. and European clients with insight into current business and legal issues in China. Chris represents multinational companies involved in commercial disputes in Asia. His engagements have included disputes over breaches of contract\, copyright infringement\, trade secrets theft\, and fraud\, both in U.S. federal and state courts and in arbitration. He also represents Chinese and Asian clients with pending investigations before U.S. prosecutors. Chris’s work has included highly sensitive matters such as money laundering and health care fraud. Chris also assists U.S. and European companies with compliance and anticorruption issues in China and East Asia. He helps clients investigate allegations of embezzlement\, conflicts of interest\, and commercial and public bribery involving their employees\, contractors\, and joint venture partners. Chris previously served eight years with the United States Department of Justice. He tried 10 felony cases before federal juries\, submitted at least 10 different appeals briefs\, and orally argued before the United States Court of Appeals on four cases. Chris has been active with several Los Angeles-based nonprofits\, including School on Wheels and the L.A. Center for Law & Justice\, as well as with Stepping Stones in Shanghai
URL:https://sapagp.org/event/the-chinese-american-experience-evolving-tensions-in-us-china-relations/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/09/9-24-2020-webinar-flyer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200910T200000
DTEND;TZID=America/New_York:20200910T210000
DTSTAMP:20260425T074604
CREATED:20200730T124257Z
LAST-MODIFIED:20221201T193021Z
UID:2780-1599768000-1599771600@sapagp.org
SUMMARY:Control Your Own Destiny
DESCRIPTION:Register hereAbout this Event\n\n\nZoom meeting information will be sent to your email address after registration. \nSpeaker:\nCynthia Cai\, M Eng\, MBA\, PhD \nPresident\,Tharton Consulting & Senior Advisor for Northern Light Capital
URL:https://sapagp.org/event/control-your-own-destiny/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/07/Screen-Shot-2020-08-02-at-11.00.50-1-e1596466196687.png
END:VEVENT
END:VCALENDAR